New data show pembrolizumab improves breast cancer outcomes regardless of age or menopausal status
by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainNew data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug pembrolizuma
Updated on: March 28,2024
New data show pembrolizumab improves breast cancer outcomes regardless of age or menopausal status
by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainNew data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug pembrolizuma
Updated on:March 28,2024
